Calciphylaxis-associated second renal graft failure and patient loss: A case report and review of the literature

Experimental and Clinical Transplantation

Volumn 6, Issue 4, 2008, Pages 287-293

  Aabed, Gamal ^a   Furayh, Othman Al ^a   Al Lehbi, Ali ^a   Mana, Hadeel Al ^b   Ghamedi, Abdulla Al ^a   Helmy, Ahmed ^b  

^a Sections of Nephrology ^*  (Saudi Arabia)

^b KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

Calciphylaxis; Parathyroidectomy; Renal transplant

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; PARATHYROID HORMONE; STEROID;

ADULT; BLOOD; CALCINOSIS; CASE REPORT; CHRONIC KIDNEY FAILURE; FATALITY; FEMALE; GRAFT REJECTION; HUMAN; HYPERPARATHYROIDISM; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PARATHYROIDECTOMY; PATHOLOGY; RENAL REPLACEMENT THERAPY; REOPERATION; REVIEW; RISK FACTOR; TREATMENT FAILURE;

ADULT; CALCIPHYLAXIS; FATAL OUTCOME; FEMALE; GRAFT REJECTION; HUMANS; HYPERPARATHYROIDISM; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PARATHYROID HORMONE; PARATHYROIDECTOMY; RENAL DIALYSIS; REOPERATION; RISK FACTORS; STEROIDS; TREATMENT FAILURE; YOUNG ADULT;

EID: 65249125687     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Mazhar AR, Johnson RJ, Gillen D, et al. Risk factors and mortality associated with calciphylaxis in end-stage renal disease. Kidney Int. 2001;60(1):324-332.
2. Wilmer WA, Magro CM. Calciphylaxis: emerging concepts in prevention, diagnosis, and treatment. Semin Dial. 2002;15(3):172-186.
3. Selye H, Gabbiani G, Strebel R. Sensitization to calciphylaxis by endogenous parathyroid hormone. Endocrinology. 1962;71:554-558.
4. Rivera-Nieves J, Bamias G, Alfert J, Bickston SJ, Moskaluk CA, Cominelli F. Intestinal ischemia and peripheral gangrene in a patient with chronic renal failure. Gastroenterology. 2002;122(2):495-499.
5. Asirvatham S, Sebastian C, Sivaram CA, Kaufman C, Chandrasekaran K. Aortic valve involvement in calciphylaxis: uremic small artery disease with medial calcification and intimal hyperplasia. Am J Kidney Dis. 1998;32(3):499-502.
6. Dominguez JM, Mautalen CA, Rodo JE, Barcat JA, Molins ME. Tertiary hyperparathyroidism diagnosed after renal homotransplantation. Am J Med. 1970;49(3):423-428.
7. Giacobetti R, Feldman SA, Ivanovich P, Huang CM, Levin ML. Sudden fatal pulmonary calcification following renal transplantation. Nephron. 1977;19(5):295-300.
8. Massry SG, Gordon A, Coburn JW, et al. Vascular calcification and peripheral necrosis in a renal transplant recipient. Reversal of lesions following subtotal parathyroidectomy. Am J Med. 1970;49(3):416-422.
9. Gipstein RM, Coburn JW, Adams DA, et al. Calciphylaxis in man. A syndrome of tissue necrosis and vascular calcification in 11 patients with chronic renal failure. Arch Intern Med. 1976;136(11):1273-1280.
10. Perloff LJ, Spence RK, Grossman RA, Barker CF. Lethal post-transplantation calcinosis. Transplantation. 1979;27(1):21-25.
11. Fox R, Banowsky LH, Cruz AB Jr. Post-renal transplant calciphylaxis: successful treatment with parathyroidectomy. J Urol. 1983;129(2):362-363.
12. Wenzel-Seifert K, Harwig S, Keller F. Fulminant calcinosis in two patients after kidney transplantation. Am J Nephrol. 1991;11(6):497-500.
13. Kloeppel R, Luebke P, Mittag M, et al. Acute hypercalcemia of the heart (bony heart). J Comput Assist Tomogr. 2001;25(3):407-411.
14. Brewster UC, Perazella MA. Calcific uremic arteriolopathy in a transplanted kidney. Am J Med Sci. 2005;329(2):102-103.
15. Vanbelleghem H, Terryn W, Van Leuven L, Van Caesbroeck D, Demetter P, Lameire N. A dramatic case of calciphylaxis 20 years after kidney transplantation. Nephrol Dial Transplant. 2004;19(12):3183-3185.
16. Wittmann I, Degrell P, Molnár GA, et al. Diagnosis and successful management of calciphylaxis in a pancreas-kidney transplant patient. Nephrol Dial Transplant. 2005;20(7):1520-1521. Erratum in: Nephrol Dial Transplant. 2005;20(10):2295.
17. Edelstein CL, Wickham MK, Kirby PA. Systemic calciphylaxis presenting as a painful, proximal myopathy. Postgrad Med J. 1992;68(797):209-211.
18. Asmundsson P, Elíasson GJ, Pórdarson H. A case of calciphylaxis. Case report. Scand J Urol Nephrol. 1988;22(2):155-157.
19. Richardson JA, Herron G, Reitz R, Layzer R. Ischemic ulcerations of skin and necrosis of muscle in azotemic hyperparathyroidism. Ann Intern Med. 1969;71(1):129-138.
20. Angelis M, Wong LL, Myers SA, Wong LM. Calciphylaxis in patients on hemodialysis: a prevalence study. Surgery. 1997;122(6):1083-1089; discussion 1089-1090.
21. Virchow R. Kalk-Metastasen. Verchows Arch 1855; (A)8:103-113.
22. Selye H. Calciphylaxis. Chicago, IL: University of Chicago Press; 1962.
23. Sakuma Y, Mori M. Experimental calcification in rat submandibular gland. Cell Mol Biol. 1992;38(4):413-427.
24. Boivin G, Walzer C, Baud CA. Ultrastructural study of the long-term development of two experimental cutaneous calcinoses (topical calciphylaxis and topical calcergy) in the rat. Cell Tissue Res. 1987;247(3):525-532.
25. Bleyer AJ, Choi M, Igwemezie B, de la Torre E, White WL. A case control study of proximal calciphylaxis. Am J Kidney Dis. 1998;32(3):376-383.
26. Coates T, Kirkland GS, Dymock RB, et al. Cutaneous necrosis from calcific uremic arteriolopathy. Am J Kidney Dis. 1998;32(3):384-391.
27. Dwyer KM, Francis DM, Hill PA, Murphy BF. Calcific uraemic arteriolopathy: local treatment and hyperbaric oxygen therapy. Nephrol Dial Transplant. 2002;17(6):1148-1149.
28. Braden G, Goerdt P, Pekow P, et al. Calciphylaxis in hemodialysis patients: patient profiles and temporal association with IV iron dextran (abstract). J Am Soc Nephrol 1997; 8:549.
29. Rubinger D, Friedlaender MM, Silver J, Kopolovic Y, Czaczkes WJ, Popovtzer MM. Progressive vascular calcification with necrosis of extremities in hemodialysis patients: a possible role of iron overload. Am J Kidney Dis. 1986;7(2):125-129.
30. Fader DJ, Kang S. Calciphylaxis without renal failure. Arch Dermatol. 1996;132(7):837-838.
31. Mori K, Shioi A, Jono S, Nishizawa Y, Morii H. Dexamethasone enhances In vitro vascular calcification by promoting osteoblastic differentiation of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1999;19(9):2112-2118.
32. Hafner J, Keusch G, Wahl C, Burg G. Calciphylaxis: a syndrome of skin necrosis and acral gangrene in chronic renal failure. Vasa. 1998;27(3):137-143.
33. McIntosh DA, Peterson EW, McPhaul JJ Jr. Autonomy of parathyroid function after renal homotransplantation. Ann Intern Med. 1966;65(5):900-907.
34. Herdman RC, Michael AF, Vernier RL, Kelly WD, Good RA. Renal function and phosphorus excretion after human renal homotransplantation. Lancet. 1966;1(7429):121-123.
35. Alfrey AC, Jenkins D, Groth CG, Schorr WS, Gecelter L, Ogden DA. Resolution of hyperparathyroidism, renal osteodystrophy and metastatic calcification after renal homotransplantation. N Engl J Med. 1968;279(25):1349-1356.
36. Geis WP, Popovtzer MM, Corman JL, Halgrimson CG, Groth CG, Starzl TE. The diagnosis and treatment of hyperparathyroidism after renal homotransplantation. Surg Gynecol Obstet. 1973;137(6):997-1010.
37. Chan YL, Mahony JF, Turner JJ, Posen S. The vascular lesions associated with skin necrosis in renal disease. Br J Dermatol. 1983;109(1):85-95.
38. Budisavljevic MN, Cheek D, Ploth DW. Calciphylaxis in chronic renal failure. J Am Soc Nephrol. 1996;7(7):978-982.
39. Westenfeld R, Jahnen-Dechent W, Ketteler M. Vascular calcification and fetuin-A deficiency in chronic kidney disease. Trends Cardiovasc Med. 2007;17(4):124-128.
40. Mehrotra R. Emerging role for fetuin-A as contributor to morbidity and mortality in chronic kidney disease. Kidney Int. 2007;72(2):137-140.
41. Hermans MM, Brandenburg V, Ketteler M, et al. Association of serum fetuin-A levels with mortality in dialysis patients. Kidney Int. 2007;72(2):202-207.
42. Caglar K, Yilmaz MI, Saglam M, et al. Short-term treatment with sevelamer increases serum fetuin-a concentration and improves endothelial dysfunction in chronic kidney disease stage 4 patients. Clin J Am Soc Nephrol. 2008;3(1):61-68.